These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8682466)

  • 1. Locoregional chemotherapy versus locoregional combined immuno-chemotherapy for patients with advanced metastatic liver disease of colorectal origin: a prospective randomized study.
    Lygidakis NJ; Stringaris K; Kokinis K; Lyberopoulos K; Raptis S
    Hepatogastroenterology; 1996; 43(7):212-20. PubMed ID: 8682466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
    Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
    Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resection versus resection combined with adjuvant pre- and post-operative chemotherapy--immunotherapy for metastatic colorectal liver cancer. A new look at an old problem.
    Lygidakis NJ; Ziras N; Parissis J
    Hepatogastroenterology; 1995 Apr; 42(2):155-61. PubMed ID: 7672764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic liver disease of colorectal origin: the value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection. Results of a prospective randomized study.
    Lygidakis NJ; Sgourakis G; Vlachos L; Raptis S; Safioleas M; Boura P; Kountouras J; Alamani M
    Hepatogastroenterology; 2001; 48(42):1685-91. PubMed ID: 11813601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial.
    Leichman CG; Jacobson JR; Modiano M; Daniels JR; Zalupski MM; Doroshow JH; Fletcher WS; Macdonald JS
    Cancer; 1999 Sep; 86(5):775-81. PubMed ID: 10463975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant hepatic arterial IL-2 and MMC, 5-FU after curative resection of colorectal liver metastases.
    Okuno K; Shigeoka H; Lee YS; Son E; Kayama H; Nakai T; Koh K; Yasutomi M
    Hepatogastroenterology; 1996; 43(9):688-91. PubMed ID: 8799416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
    Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
    Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
    Witte RS; Cnaan A; Mansour EG; Barylak E; Harris JE; Schutt AJ
    Cancer; 2001 Mar; 91(5):1020-8. PubMed ID: 11251955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-arterial infusion of 5-fluorouracil plus granulocyte-macrophage colony-stimulating factor (GM-CSF) and chemoembolization with melphalan in the treatment of disseminated colorectal liver metastases.
    Müller H; Nakchbandi W; Chatzissavvidis I; Valek V
    Eur J Surg Oncol; 2001 Nov; 27(7):652-61. PubMed ID: 11669594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incomplete operative removal of colorectal liver metastases followed by chemotherapy decreases survival in comparison to chemotherapy alone.
    Popov IP; Milicevic M; Kecmanovic D; Tomasevic Z; Radosevic-Jelic Lj; Borojevic N; Micev MT; Kezic I
    J Exp Clin Cancer Res; 2006 Sep; 25(3):313-9. PubMed ID: 17167970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
    Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional chemoimmunotherapy for nonresectable metastatic liver disease of colorectal origin. A prospective randomized study.
    Lygidakis NJ; Sgourakis G; Dedemadi G; Safioleus MC; Nestoridis J
    Hepatogastroenterology; 2001; 48(40):1085-7. PubMed ID: 11490806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.
    Van Hazel G; Blackwell A; Anderson J; Price D; Moroz P; Bower G; Cardaci G; Gray B
    J Surg Oncol; 2004 Nov; 88(2):78-85. PubMed ID: 15499601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective study on the effects of lipiodolization before a potentially curative hepatectomy for colorectal liver metastases: long-term results of a pilot study.
    Utsunomiya T; Emi Y; Ikejiri K; Suzuki M; Saitsu H; Yakabe S; Nonaka M; Saku M; Yoshida K; Shimada M; Sugimachi K
    Hepatogastroenterology; 2001; 48(39):790-3. PubMed ID: 11462925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Personal experience with intra-arterial locoregional chemotherapy of liver metastases from colorectal carcinoma].
    Kiss I; Marková J; Tomásek J; Vyzula R; Válek V; Boudný J; Kala Z; Hanke I; Ostrízek T; Leypold J
    Vnitr Lek; 2001 Dec; 47(12):829-33. PubMed ID: 11826545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.
    da Silva RG; Sugarbaker PH
    J Am Coll Surg; 2006 Dec; 203(6):878-86. PubMed ID: 17116556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver.
    Salman HS; Cynamon J; Jagust M; Bakal C; Rozenblit A; Kaleya R; Negassa A; Wadler S
    Clin Colorectal Cancer; 2002 Nov; 2(3):173-9. PubMed ID: 12482334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of metastatic colorectal cancer: analysis of a consecutive series of 229 patients. The impact of a multidisciplinary approach.
    Sperti E; Faggiuolo R; Gerbino A; Magnino A; Muratore A; Ortega C; Ferraris R; Leone F; Capussotti L; Aglietta M
    Dis Colon Rectum; 2006 Oct; 49(10):1596-601. PubMed ID: 16988853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre- and post- operative adjuvant targeting locoregional chemotherapy combined with locoregional targeting immunostimulation and surgical resection for hepatocellular carcinoma. A new promising alternative.
    Lygidakis NJ; Konstantinidou T; Pothoulakis J
    Anticancer Res; 1994; 14(3B):1351-5. PubMed ID: 8067704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer metastases: surgical indications and multimodal approach.
    Ciferri E; Bondanza GS; Municinò O; Castagnola M; Gazzaniga GM
    Hepatogastroenterology; 2003; 50(54):1836-46. PubMed ID: 14696416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.